Ucb Biopharma Srl

This study tested a new medicine called UCB9741 in healthy volunteers and people with moderate-to-severe atopic dermatitis (eczema). The main goal was to check if the drug is safe and how the body processes it. Researchers also looked for early signs that the drug might improve e…

This study tested a drug called rozanolixizumab in 200 adults with generalized myasthenia gravis, a condition causing muscle weakness. Participants received either the drug or a placebo to see if it improved daily activities like talking, swallowing, and breathing. The goal was t…

This study looked at 26 adults with generalized myasthenia gravis, a condition that causes muscle weakness. They switched from an IV medicine to a daily shot called zilucoplan. The main goal was to see if the switch was safe and well-tolerated. Results help offer a more convenien…

This study tested a drug called bimekizumab in 274 adults with a form of spinal arthritis that doesn't show up on X-rays (nonradiographic axial spondyloarthritis). The goal was to see if the drug reduces pain, stiffness, and improves daily function better than a placebo. Particip…

This study looked at the long-term safety of bimekizumab, a drug for moderate to severe plaque psoriasis, in over 1,300 adults. Participants who had completed earlier studies received the drug for up to several years. The main goal was to track side effects and see how well the b…

This study tested a new drug called bimekizumab in 49 adults with moderate to severe plaque psoriasis. The goal was to see how well it clears skin, how long it stays in the body, and if it is safe. Participants received the drug and were followed for 28 weeks to track changes in …

This study tested an experimental oral drug called UCB0599 in 496 people with early-stage Parkinson's disease. The goal was to see if the drug could safely slow down the worsening of symptoms like movement and daily living problems compared to a placebo over 18 months. Researcher…

This study tested a new drug called bimekizumab against an existing drug, secukinumab, in 743 adults with moderate to severe plaque psoriasis. The main goal was to see how many people achieved complete skin clearance after 16 weeks of treatment. Both drugs are biologics that help…

This study tested a drug called bimekizumab against a placebo in 435 adults with moderate to severe plaque psoriasis. The goal was to see if the drug could clear or nearly clear skin patches. Results showed significant improvement in skin symptoms for those taking bimekizumab.

This study looked at the long-term safety and effectiveness of the drug brivaracetam in 84 children and young adults (ages 2 to 26) with childhood or juvenile absence epilepsy. Absence epilepsy causes brief staring spells. The goal was to see if the drug is safe to take over a lo…

This early-stage study tested a new drug called UCB0022 in 100 healthy volunteers and people with Parkinson's disease. The main goal was to check if the drug is safe and how the body processes it. Researchers also looked at how food affects the drug. This is a first step to see i…

This study looked at how a new tablet version of the drug minzasolmin is absorbed by the body compared to an older capsule form. It also checked if eating food changes how the tablet works. Eighteen healthy adults took part to help researchers understand the drug's behavior, not …